Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350649 · ClinicalTrials.gov registry record · Phase 2
Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 205
- Enrollment target
NCT00350649 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 205 participants.
The verdict
NCT00350649, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 205 participants
- Enrollment target
Study Summary
Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated with enhanced treatment outcomes in CBT. Contingency management (CM) also has very strong support and is associated with rapid, robust effects on targeted outcomes. Despite their many strengths, neither CBT nor CM is universally effective. It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects.
Interventions
- BEHAVIORAL Standard CBT
- BEHAVIORAL CBT+CM/adherence
- BEHAVIORAL CM/abstinence
- BEHAVIORAL CM/abstinence+CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2004-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350649
The ClinicalTrials.gov registry entry for NCT00350649 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Standard CBT is the first listed.
NCT00350649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350649 about?
NCT00350649 is a clinical study titled "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management". Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated w...
What is the current status of trial NCT00350649?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 205 participants. The study started on 2004-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00350649?
The interventions under investigation include: Standard CBT (BEHAVIORAL), CBT+CM/adherence (BEHAVIORAL), CM/abstinence (BEHAVIORAL), CM/abstinence+CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00350649?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.